Charmacy Pharmaceutical Co., Ltd.
Climate Impact & Sustainability Data (2020, 2022, 2023)
Reporting Period: 2020
Environmental Metrics
ESG Focus Areas
- Product Quality and Safety
- Supply Chain Management
- Staff Health and Safety
- Staff Development and Training
- Compliant Employment and Staff Welfare
- Anti-corruption Measures
- Utilisation of Resources and Environmental Protection
- Waste Disposal
- Greenhouse Gas Emissions
- Social Welfare
Environmental Achievements
- Complied with applicable environmental regulations; no major violations.
- Implemented waste paper recycling, paperless office, and water conservation initiatives.
- Reduced petroleum gas usage and planned photovoltaic power generation for 2021.
Social Achievements
- Provided competitive salaries and benefits, employee activities, and free meals/housing.
- Maintained a low employee turnover rate (22.72%).
- Donated anti-epidemic supplies and conducted community welfare activities.
Governance Achievements
- Established an ESG Work Panel to oversee ESG matters.
- Implemented anti-corruption policies and grievance mechanisms.
- No bribery, extortion, fraud, or money laundering incidents reported.
Climate Goals & Targets
- Not disclosed
- Not disclosed
- Not disclosed
Environmental Challenges
- Increased emissions in 2020 due to new vehicle purchases, increased use of refrigerated trucks, and expansion of logistics centers.
- Increased waste generation in 2020 due to business expansion.
Mitigation Strategies
- Monitoring new energy vehicles for future adoption.
- Implementing resource-saving initiatives (recycling, paperless office, water conservation).
- Utilizing intelligent lighting control systems in new logistics centers.
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Supplier selection based on purchasing scale, sales policies, and quality assessment.
- Annual quality review of suppliers.
- Quality assurance agreements with suppliers.
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Appendix 27 of the Rules Governing the Listing of Securities of The Stock Exchange of Hong Kong Limited
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Model Enterprise of Integrity in Guangdong Province
- Contract Abiding and Credit Respecting Enterprise in Guangdong Province
- Enterprise Having Great Love and Undertaking Responsibility in War against Epidemic
- Golden Ant Innovation Award of Chinese logistics industry
- Best pharmaceutical supply chain logistics centre (base)
- Best pharmaceutical supply chain logistics service enterprise
- Top-100 outstanding private pharmaceutical commercial circulation enterprises in China
Reporting Period: 2022
Environmental Metrics
ESG Focus Areas
- Environmental
- Social
- Governance
Environmental Achievements
- Complied with applicable environmental regulations in operating locations; no major violations.
- Greenhouse gas emissions decreased from 7,745.86 tonnes of CO2e in 2021 to 6,889.10 tonnes of CO2e in 2022.
- Waste reduction initiatives implemented, including recycling of used cartons and promotion of paperless office.
Social Achievements
- Provided competitive salaries and benefits, including employee canteen, dormitories, and various welfare programs.
- Organized employee activities, such as training programs and celebrations.
- Maintained a low employee turnover rate (30.59% in 2022, compared to 31.49% in 2021).
Governance Achievements
- Established an ESG work panel to oversee ESG-related matters.
- Implemented policies and procedures to prevent bribery, extortion, fraud, and money laundering.
- No corruption lawsuits filed against the company or its employees.
Climate Goals & Targets
- Not disclosed
- Negative growth in carbon intensity.
- Further improve water resource utilization rate.
- Continuously improve energy use efficiency and seek opportunities for clean energy.
- Stable reduction in exhaust emissions.
- Stable reduction in waste intensity.
Environmental Challenges
- Potential disruptions to operations due to extreme weather events (typhoons, rainstorms).
- Increased energy and fuel consumption due to prolonged high temperatures.
- Potential for traffic accidents involving transportation personnel.
Mitigation Strategies
- Established emergency response procedures for climate-related incidents.
- Regularly conducted disaster prevention and preparedness activities.
- Gradual elimination of high-energy consumption equipment and improvement of resource efficiency.
Supply Chain Management
Supplier Audits: Annual quality appraisal of suppliers.
Responsible Procurement
- Strict supplier qualification review mechanism.
- On-site inspections of suppliers.
- Pharmaceutical Commodities Quality Assurance Agreement with suppliers.
Climate-Related Risks & Opportunities
Physical Risks
- Disruptions to water and power supply due to extreme weather.
- Damage to goods during transportation due to extreme weather.
- Increased energy and fuel consumption due to high temperatures.
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Appendix 27 of the Rules Governing the Listing of Securities of The Stock Exchange of Hong Kong Limited
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Recommended pharmaceutical cold chain logistics services enterprise (3 consecutive years)
- Best logistics center (base) of pharmaceutical cold chain (4 consecutive years)
- Excellent pharmaceutical logistics and distribution enterprise (2 consecutive years)
- Modern pharmaceutical logistics technology experimental base (center)
- Golden Ant Innovation Award for China’s Logistics Industry (5 consecutive years)
- Certificate of participation in Guangdong enterprises’ growing business in good faith (11 consecutive years)
- 2022 China Pharmaceutical Supply Chain Sharp Enterprise
Reporting Period: 2023
Environmental Metrics
ESG Focus Areas
- Product Quality and Safety
- Supply Chain Management
- Staff Health and Safety
- Staff Development and Training
- Compliant Employment and Staff Welfare
- Anti-corruption Measures
- Greenhouse Gas Emissions
- Utilisation of Resources and Environmental Protection
- Waste Disposal
- Tackling Climate Change
- Social Welfare
Environmental Achievements
- Complied with environmental regulations in operating locations; no major violations.
- Implemented waste reduction initiatives, including recycling and reuse of packaging materials.
- Implemented energy efficiency measures, including smart lighting and photovoltaic power generation.
Social Achievements
- Provided competitive salaries and benefits, including employee meals and housing.
- Organized various employee activities to enhance cultural life and skills.
- Maintained a low employee turnover rate (21.48%).
- Provided comprehensive training programs for employees (average 11.70 hours per employee).
Governance Achievements
- Established an ESG working group to oversee and promote ESG initiatives.
- Implemented anti-corruption policies and training programs.
- Established multiple channels for complaints and reporting of employee misconduct.
Climate Goals & Targets
- Not disclosed
- Not disclosed
- Reduce greenhouse gas emission intensity by 5% by 2034 compared to 2023.
- Reduce waste intensity by 10% by 2034 compared to 2023.
- Reduce water consumption per RMB 10,000 of operating revenue by 5% by 2034 compared to 2023.
Environmental Challenges
- Potential disruptions to warehouse and office operations due to extreme weather events.
- Potential delays and damage to goods during transportation due to extreme weather.
- Increased energy and fuel consumption due to high temperatures.
- Product quality risks, out-of-stock risks, and unsalable risks in the supply chain.
Mitigation Strategies
- Established emergency procedures for climate change-related incidents.
- Regularly conducted natural disaster prevention and preparedness activities.
- Gradually phasing out high-energy consumption equipment.
- Implemented measures to mitigate product quality, out-of-stock, and unsalable risks, including strict quality control, inventory management, and emergency plans.
Supply Chain Management
Supplier Audits: Annual quality appraisal of suppliers.
Responsible Procurement
- Strict supplier qualification review mechanism; on-site inspections; quality assurance agreements.
Climate-Related Risks & Opportunities
Physical Risks
- Disruptions to water and power supply due to extreme weather.
- Delays and damage to goods during transportation.
Transition Risks
- Increased energy and fuel consumption due to high temperatures.
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Appendix C2 of the Rules Governing the Listing of Securities of The Stock Exchange of Hong Kong Limited
Certifications: Various awards related to pharmaceutical logistics and supply chain management
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Various awards related to pharmaceutical logistics and supply chain management